C F Bladin1,2, N Moloczij3, S Ermel4, K L Bagot1, M Kilkenny5, M Vu1, D A Cadilhac1,5. 1. Stroke Division, Florey Institute of Neuroscience and Mental Health, Melbourne, Victoria, Australia. 2. Eastern Health Clinical School, Monash University, Melbourne, Victoria, Australia. 3. Medical and Cognitive Research Unit, Austin Health, Melbourne, Victoria, Australia. 4. Bendigo Health, Bendigo, Victoria, Australia. 5. Translational Public Health Unit, Stroke and Ageing Research Centre, Department of Medicine, School of Clinical Sciences at Monash Health, Monash University, Melbourne, Victoria, Australia.
Abstract
BACKGROUND: Stroke telemedicine is widely used to treat patients with acute stroke in Europe and North America but is seldom used in Australia. The Victorian Stroke Telemedicine (VST) programme aims to enhance acute stroke care in regional Australia. METHODS: Twelve-month pilot prospective, historical-controlled, implementation cohort study. Emergency Department (ED) at a large regional hospital in Victoria. Patients ≥ 18 years of age arriving < 4.5 h in the ED with a possible diagnosis of acute stroke. Telemedicine consultation by a Melbourne-based stroke specialist. Stroke thrombolysis rate, timelines for clinical processes, discharge outcomes. RESULTS: In the initial 12 month VST implementation, 62 patients arrived < 4.5 h of stroke onset (60% male; median age 75 years). Compared to pre-VST data (n = 58; 52% male; median age 77 years), stroke thrombolysis use increased from 17% to 26% (P = 0.26). Clinical process timelines improved including door to computed tomography time (reduced by 29 min, P = 0.006), and door to needle time (reduced by 21 min, P = 0.21). There was no significant increase in deaths (pre-VST 7% vs VST 10%), or symptomatic intracerebral haemorrhage (n = 1 tPA patient). More patients who received tPA were discharged to home or rehabilitation (pre-VST 33% vs VST 80%, P = 0.02), with significantly fewer transfers to other acute care services. CONCLUSIONS: The VST pilot implementation provides evidence that telemedicine can enhance the quality of acute stroke care in a regional hospital. Expanding VST to 16 regional hospitals, Australia's largest telestroke programme, will allow for a more comprehensive clinical and economic analysis.
BACKGROUND:Stroke telemedicine is widely used to treat patients with acute stroke in Europe and North America but is seldom used in Australia. The Victorian Stroke Telemedicine (VST) programme aims to enhance acute stroke care in regional Australia. METHODS: Twelve-month pilot prospective, historical-controlled, implementation cohort study. Emergency Department (ED) at a large regional hospital in Victoria. Patients ≥ 18 years of age arriving < 4.5 h in the ED with a possible diagnosis of acute stroke. Telemedicine consultation by a Melbourne-based stroke specialist. Stroke thrombolysis rate, timelines for clinical processes, discharge outcomes. RESULTS: In the initial 12 month VST implementation, 62 patients arrived < 4.5 h of stroke onset (60% male; median age 75 years). Compared to pre-VST data (n = 58; 52% male; median age 77 years), stroke thrombolysis use increased from 17% to 26% (P = 0.26). Clinical process timelines improved including door to computed tomography time (reduced by 29 min, P = 0.006), and door to needle time (reduced by 21 min, P = 0.21). There was no significant increase in deaths (pre-VST 7% vs VST 10%), or symptomatic intracerebral haemorrhage (n = 1 tPApatient). More patients who received tPA were discharged to home or rehabilitation (pre-VST 33% vs VST 80%, P = 0.02), with significantly fewer transfers to other acute care services. CONCLUSIONS: The VST pilot implementation provides evidence that telemedicine can enhance the quality of acute stroke care in a regional hospital. Expanding VST to 16 regional hospitals, Australia's largest telestroke programme, will allow for a more comprehensive clinical and economic analysis.
Authors: E Ray Dorsey; Alistair M Glidden; Melissa R Holloway; Gretchen L Birbeck; Lee H Schwamm Journal: Nat Rev Neurol Date: 2018-04-06 Impact factor: 42.937
Authors: Amir Alishahi Tabriz; Kea Turner; Dunc Williams; Nimmy Babu; Steve North; Christopher M Shea Journal: Telemed J E Health Date: 2021-09-24 Impact factor: 5.033
Authors: Lan Gao; Elise Tan; Joosup Kim; Christopher F Bladin; Helen M Dewey; Kathleen L Bagot; Dominique A Cadilhac; Marj Moodie Journal: Front Neurol Date: 2022-06-20 Impact factor: 4.086
Authors: Christopher R Levi; John A Attia; Cate D'Este; Annika E Ryan; Frans Henskens; Erin Kerr; Mark W Parsons; Robert W Sanson-Fisher; Christopher F Bladin; Richard I Lindley; Sandy Middleton; Christine L Paul Journal: J Am Heart Assoc Date: 2020-01-24 Impact factor: 5.501
Authors: Md Golam Hasnain; John R Attia; Shahinoor Akter; Tabassum Rahman; Alix Hall; Isobel J Hubbard; Christopher R Levi; Christine L Paul Journal: Implement Sci Date: 2020-11-04 Impact factor: 7.327
Authors: Kathleen L Bagot; Dominique A Cadilhac; Christopher F Bladin; Caroline L Watkins; Michelle Vu; Geoffrey A Donnan; Helen M Dewey; Hedley C A Emsley; D Paul Davies; Elaine Day; Gary A Ford; Christopher I Price; Carl R May; Alison S R McLoughlin; Josephine M E Gibson; Catherine E Lightbody Journal: BMC Health Serv Res Date: 2017-11-21 Impact factor: 2.655